Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines ( vol 385 , pg 320 , 2021)

被引：0
|
作者：
Thompson, Mark G.
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 390卷 / 08期
关键词：
D O I：
10.1056/NEJMx210021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines (N Engl J Med 2021;385:320-329). In the "Attenuation of Viral RNA Load with Vaccination" subsection of Results (page 325), the second sentence should have read, "The mean viral RNA load was 3.8 log(10) copies per microliter among unvaccinated participants and 2.3 log(10) copies per microliter" rather than "... 3.8 log(10) copies per milliliter ... and 2.3 log(10) copies per milliliter." In Table 3 (page 327), the unit for the mean viral RNA load should have been log(10) copies/mu l rather than log(10) copies/ml. The article is correct at NEJM.org. . . .
引用
收藏
页码：772 / 772
页数：1
相关论文
共 50 条
  • [31] Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of Age
    Dalapati, Trisha
    Williams, Caitlin A.
    Giorgi, Elena E.
    Hurst, Jillian H.
    Herbek, Savannah
    Chen, Jui-Lin
    Kosman, Christina
    Rotta, Alexandre T.
    Turner, Nicholas A.
    Pulido, Natalie
    Aquino, Jhoanna N.
    Pfeiffer, Trevor S.
    Rodriguez, Javier
    Fouda, Genevieve G.
    Permar, Sallie R.
    Kelly, Matthew S.
    PEDIATRICS, 2024, 153 (06)
  • [32] Comparison of cytokine production in mice inoculated with messenger RNA vaccines BNT162b2 and mRNA-1273
    Nakayama, Tetsuo
    Sawada, Akihito
    Ito, Takeshi
    MICROBIOLOGY AND IMMUNOLOGY, 2023, 67 (03) : 120 - 128
  • [33] Incidence of Severe COVID-19 Illness Following Vaccination and Booster With BNT162b2, mRNA-1273, and Ad26.COV2.S Vaccines
    Kelly, J. Daniel
    Leonard, Samuel
    Hoggatt, Katherine J.
    Boscardin, W. John
    Lum, Emily N.
    Moss-Vazquez, Tristan A.
    Andino, Raul
    Wong, Joseph K.
    Byers, Amy
    Bravata, Dawn M.
    Tien, Phyllis C.
    Keyhani, Salomeh
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (14): : 1427 - 1437
  • [34] Cellular and Humoral Responses in Dialysis Patients after Vaccination with the BNT162b2 or mRNA-1273 Vaccines
    Mavrovouniotis, Ilias
    Fylaktou, Asimina
    Stagou, Maria
    Ouranos, Konstantinos
    Lioulios, Georgios
    Evgenikaki, Efthimia
    Exindari, Maria
    Gioula, Georgia
    LIFE-BASEL, 2023, 13 (02):
  • [35] Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera
    Hickey, Thomas E.
    Mudunuri, Uma
    Hempel, Heidi A.
    Kemp, Troy J.
    Roche, Nancy V.
    Talsania, Keyur
    Sellers, Brian A.
    Cherry, James M.
    Pinto, Ligia A.
    FRONTIERS IN IMMUNOLOGY, 2025, 15
  • [36] BNT162b2 versus mRNA-1273 Third Dose COVID-19 Vaccine in Patients with CKD and Maintenance Dialysis Patients
    Yau, Kevin
    Tam, Paul
    Chan, Christopher T.
    Hu, Queenie
    Qi, Freda
    Abe, Kento T.
    Kurtesi, Alexandra
    Jiang, Yidi
    Estrada-Codecido, Jose
    Brown, Tyler
    Liu, Lisa
    Siwakoti, Aswani
    Leis, Jerome A.
    Levin, Adeera
    Oliver, Matthew J.
    Colwill, Karen
    Gingras, Anne-Claude
    Hladunewich, Michelle A.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (01): : 85 - 97
  • [37] Comparative Effectiveness of the Bivalent COVID-19 mRNA Vaccines mRNA1273-222 and BNT162b2 in Adults with Diabetes in the US
    Kopel, Hagit
    Van Hung Nguyen
    Bogdanov, Alina
    Winer, Isabelle
    Boileau, Catherine
    Ducruet, Thierry
    Zeng, Ni
    Bausch-Jurken, Mary
    Esposito, Daina B.
    Beck, Ekkehard
    Bonafede, Mac
    Mansi, James A.
    DIABETES, 2024, 73
  • [38] BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
    Patrick Tang
    Mohammad R. Hasan
    Hiam Chemaitelly
    Hadi M. Yassine
    Fatiha M. Benslimane
    Hebah A. Al Khatib
    Sawsan AlMukdad
    Peter Coyle
    Houssein H. Ayoub
    Zaina Al Kanaani
    Einas Al Kuwari
    Andrew Jeremijenko
    Anvar Hassan Kaleeckal
    Ali Nizar Latif
    Riyazuddin Mohammad Shaik
    Hanan F. Abdul Rahim
    Gheyath K. Nasrallah
    Mohamed Ghaith Al Kuwari
    Hamad Eid Al Romaihi
    Adeel A. Butt
    Mohamed H. Al-Thani
    Abdullatif Al Khal
    Roberto Bertollini
    Laith J. Abu-Raddad
    Nature Medicine, 2021, 27 : 2136 - 2143
  • [39] Comparative effectiveness of the bivalent COVID-19 mRNA vaccines, mRNA1273-222 and BNT162b2, in immunocompromised adults in the US
    Kopel, Hagit
    Nguyen, Van Hung
    Bogdanov, Alina
    Winer, Isabelle
    Boileau, Catherine
    Ducruet, Thierry
    Zeng, Ni
    Bausch-Jurken, Mary
    Esposito, Daina B.
    Beck, Ekkehard
    Mac Bonafede
    Mansi, James A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
    Tang, Patrick
    Hasan, Mohammad R.
    Chemaitelly, Hiam
    Yassine, Hadi M.
    Benslimane, Fatiha M.
    Al Khatib, Hebah A.
    AlMukdad, Sawsan
    Coyle, Peter
    Ayoub, Houssein H.
    Al Kanaani, Zaina
    Al Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar Hassan
    Latif, Ali Nizar
    Shaik, Riyazuddin Mohammad
    Abdul Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al Kuwari, Mohamed Ghaith
    Al Romaihi, Hamad Eid
    Butt, Adeel A.
    Al-Thani, Mohamed H.
    Al Khal, Abdullatif
    Bertollini, Roberto
    Abu-Raddad, Laith J.
    NATURE MEDICINE, 2021, 27 (12) : 2136 - +
12345